Evidence map›Paper›PMID 32120930›Full record

ReviewMolecules (Basel, Switzerland)2020

Essential Oils and Mono/bi/tri-Metallic Nanocomposites as Alternative Sources of Antimicrobial Agents to Combat Multidrug-Resistant Pathogenic Microorganisms: An Overview.

Nagaraj Basavegowda, Jayanta Kumar Patra, Kwang-Hyun Baek

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The Potential ofFoods (Basel, Switzerland) · 2024
    Article
  6. Antibiotics (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antibacterial and Antibiofilm Efficacy of Thyme (Antibiotics (Basel, Switzerland) · 2023
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nagaraj BasavegowdaDepartment of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 38451, Korea.
Jayanta Kumar PatraResearch Institute of Biotechnology and Medical Converged Science, Dongguk University-Seoul, Goyang 10326, Korea.
Kwang-Hyun BaekDepartment of Biotechnology, Yeungnam University, Gyeongsan, Gyeongbuk 38451, Korea.
Yeungnam University · KRDongguk University · KR

Funding

National Research Foundation of Korea, Republic of Korea NRF-2019R1F1A1052625
6 · The paper itself

Abstract

Over the past few decades, many pathogenic bacteria have become resistant to existing antibiotics, which has become a threat to infectious disease control worldwide. Hence, there has been an extensive search for new, efficient, and alternative sources of antimicrobial agents to combat multidrug-resistant pathogenic microorganisms. Numerous studies have reported the potential of both essential oils and metal/metal oxide nanocomposites with broad spectra of bioactivities including antioxidant, anticancer, and antimicrobial attributes. However, only monometallic nanoparticles combined with essential oils have been reported on so far with limited data. Bi- and tri-metallic nanoparticles have attracted immense attention because of their diverse sizes, shapes, high surface-to-volume ratios, activities, physical and chemical stability, and greater degree of selectivity. Combination therapy is currently blooming and represents a potential area that requires greater attention and is worthy of future investigations. This review summarizes the synergistic effects of essential oils with other antimicrobial combinations such as mono-, bi-, and tri-metallic nanocomposites. Thus, the various aspects of this comprehensive review may prove useful in the development of new and alternative therapeutics against antibiotic resistant pathogens in the future.

Indexed as

Anti-Infective AgentsAntioxidantsBacteriaDrug Resistance, Multiple, BacterialDrug SynergismHumansMetal NanoparticlesNanocompositesOils, VolatilePlant ExtractsAnti-Infective AgentsAntioxidantsOils, VolatilePlant Extractsantimicrobial activitiesbi-metallic nanoparticlesessential oilmultidrug-resistant pathogenssynergistic effecttri-metallic nanoparticles

Identifiers

PMID32120930
PMCPMC7179174
OpenAlexW3009249460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.